ADHERENCE AND DISCONTINUATION OF ORAL 5-AMINOSALICYLIC ACID AMONGST ADOLESCENTS AND YOUNG ADULTS WITH ULCERATIVE COLITIS

被引：0
|
作者：
Jayasooriya, Nishani [1 ,2 ]
Pollok, Richard [1 ,2 ]
Blackwell, Jonathan [1 ,2 ]
Petersen, Irene [3 ]
Bottle, Alex [2 ]
Creese, Hanna [2 ]
Saxena, Sonia [2 ]
机构：
[1] St Georges Univ Hosp, London, England
[2] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England
[3] UCL, Inst Epidemiol & Hlth, London, England
来源：
GUT | 2021年 / 70卷
关键词：
D O I：
10.1136/gutjnl-2021-BSG.54
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
HMO-2
引用
收藏
页码：A30 / A31
页数：2
相关论文
共 50 条
  • [21] Qualitative investigation of patient adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis
    Moshkovska, Tetyana
    Stone, Margaret
    Baker, Richard
    Mayberry, John
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (06) : 763 - 768
  • [22] 5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
    Miyoshi, Jun
    Matsuoka, Katsuyoshi
    Yoshida, Atsushi
    Naganuma, Makoto
    Hisamatsu, Tadakazu
    Yajima, Tomoharu
    Inoue, Nagamu
    Okamoto, Susumu
    Iwao, Yasushi
    Ogata, Iiaruhiko
    Ueno, Fumiaki
    Hibi, Toshifumi
    Kanai, Takanori
    INTESTINAL RESEARCH, 2018, 16 (04) : 635 - 640
  • [23] MAINTENANCE OF REMISSION IN ULCERATIVE-COLITIS WITH ORAL PREPARATION OF 5-AMINOSALICYLIC ACID - REPLY
    DEW, MJ
    BRITISH MEDICAL JOURNAL, 1982, 285 (6351): : 1355 - 1355
  • [24] Risk factors for intolerance of oral 5-aminosalicylic acid preparations in pediatric ulcerative colitis
    Abe, Naoki
    Iwata, Naomi
    Yasuoka, Ryuhei
    Nishida, Daisuke
    Oohara, Asami
    Nakaseko, Haruna
    Sugiura, Shiro
    Kawabe, Shinji
    PEDIATRICS INTERNATIONAL, 2023, 65 (01)
  • [25] PREDICTORS OF NONPERSISTENCE AND NONADHERENCE WITH ORAL 5-AMINOSALICYLIC ACID THERAPY IN PATIENTS WITH ULCERATIVE COLITIS
    Yen, L.
    Wu, J.
    Hodgkins, P.
    Nichol, M. B.
    VALUE IN HEALTH, 2012, 15 (04) : A140 - A140
  • [26] Oral 5-aminosalicylic acid use in ulcerative colitis requiring biological therapy: Is it worth it?
    Bohra, A.
    Koh, E.
    Sandhu, M.
    Ling, S.
    Be, K.
    Lovett, G.
    Romero, S.
    Rajadurai, A.
    Moore, G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 145 - 146
  • [27] Modern use of 5-aminosalicylic acid compounds for ulcerative colitis
    Le Berre, Catherine
    Roda, Giulia
    Protic, Marijana Nedeljkovic
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (04) : 363 - 378
  • [28] TREATMENT OF ULCERATIVE-COLITIS WITH 5-AMINOSALICYLIC ACID - RESPONSE
    SUTHERLAND, LR
    MAY, G
    SHAFFER, E
    ANNALS OF INTERNAL MEDICINE, 1993, 119 (08) : 859 - 859
  • [29] Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis
    Marshall, John K.
    Thabane, Marroon
    Steinhart, A. Hillary
    Newman, Jamie R.
    Anand, Anju
    Irvine, E. Jan
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (01):
  • [30] Adherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitis: impact on all-cause healthcare costs
    Debanjali, M.
    Hodgkins, P.
    Yen, L.
    Solomon, D.
    Davis, K.
    Cohen, R.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S32 - S32
12345